Therapeutic potential of Kupffer cells in prevention of liver metastases outgrowth

Immunobiology

Volumn 210, Issue 2-4, 2005, Pages 259-265

  van der Bij, Gerben J ^a   Oosterling, Steven J ^a   Meijer, Sybren ^a   Beelen, Robert H J ^a   van Egmond, Marjolein ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Colon carcinoma; Cytotoxicity; Hepatic metastasis; Kupffer cell; Macrophage

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; EDRECOLOMAB; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MONOCLONAL ANTIBODY; MURAMYL DIPEPTIDE DERIVATIVE; MURAMYL TRIPEPTIDE; OLIGODEOXYNUCLEOTIDE DERIVATIVE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CELL FUNCTION; CELL MEDIATED CYTOTOXICITY; CLINICAL TRIAL; COLORECTAL CANCER; GASTROINTESTINAL TUMOR; HUMAN; IMMUNOSTIMULATION; KUPFFER CELL; LIVER CELL; LIVER METASTASIS; LIVER SINUSOID; NONHUMAN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

EID: 22644441571     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2005.05.020     Document Type: Review

References (54)

1. G. Atkin A. Chopada I. Mitchell Colorectal cancer metastasis: In the surgeon's hands? Int. Semin. Surg. Oncol. 2 2005 5
2. M. Balzar M.J. Winter C.J. de Boer S.V. Litvinov The biology of the 17-1A antigen (Ep-CAM) J. Mol. Med. 77 1999 699-712
3. L.G. Bayon M.A. Izquierdo I. Sirovich N. van Rooijen R.H. Beelen S. Meijer Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver Hepatology 23 1996 1224-1231
4. R.D. Blumenthal L. Osorio M.K. Hayes I.D. Horak H.J. Hansen D.M. Goldenberg Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft Cancer Immunol. Immunother. 54 2005 315-327
5. L. Bouwens M. Baekeland R. De Zanger E. Wisse Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver Hepatology 6 1986 718-722
6. D. Chantry M. Turner F. Brennan A. Kingsbury M. Feldmann Granulocyte-macrophage colony stimulating factor induces both HLA-DR expression and cytokine production by human monocytes Cytokine 2 1990 60-67
7. R.A. Clynes T.L. Towers L.G. Presta J.V. Ravetch Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets Nat. Med. 6 2000 443-446
8. J.C. Coffey J.H. Wang M.J. Smith D. Bouchier-Hayes T.G. Cotter H.P. Redmond Excisional surgery for cancer cure: Therapy at a cost Lancet Oncol. 4 2003 760-768
9. A. Enns P. Gassmann K. Schluter T. Korb H.U. Spiegel N. Senninger J. Haier Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids J. Gastrointest. Surg. 8 2004 1049-1059
10. E. Faist C. Schinkel S. Zimmer Update on the mechanisms of immune suppression of injury and immune modulation World J. Surg. 20 1996 454-459
11. W.E. Fogler R. Wade D.E. Brundish I.J. Fidler Distribution and fate of free and liposome-encapsulated [3H]nor-muramyl dipeptide and [3H]muramyl tripeptide phosphatidylethanolamine in mice J. Immunol. 135 1985 1372-1377
12. G. Fusai B.R. Davidson Management of colorectal liver metastases Colorectal Dis. 5 2003 2-23
13. K.H. Grabstein D.L. Urdal R.J. Tushinski D.Y. Mochizuki V.L. Price M.A. Cantrell S. Gillis P.J. Conlon Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor Science 232 1986 506-508
14. R.T. Greenlee M.B. Hill-Harmon T. Murray M. Thun Cancer statistics, 2001 CA Cancer J. Clin. 51 2001 15-36
15. G. Heuff H.S. Oldenburg H. Boutkan J.J. Visser R.H. Beelen N. van Rooijen C.D. Dijkstra S. Meyer Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells Cancer Immunol. Immunother. 37 1993 125-130
16. A.D. Hill H.P. Redmond H.A. Naama D. Bouchier-Hayes Granulocyte-macrophage colony-stimulating factor inhibits tumor growth during the postoperative period Surgery 119 1996 178-185
17. B. Jahrsdorfer G.J. Weiner Immunostimulatory CpG oligodeoxynucleotides and antibody therapy of cancer Semin. Oncol. 30 2003 476-482
18. H.M. Karpoff W. Jarnagin K. Delman Y. Fong Regional muramyl tripeptide phosphatidylethanolamine administration enhances hepatic immune function and tumor surveillance Surgery 128 2000 213-218
19. T. Keler P.K. Wallace L.A. Vitale C. Russoniello K. Sundarapandiyan R.F. Graziano Y.M. Deo Differential effect of cytokine treatment on Fc alpha receptor I- and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages J. Immunol. 164 2000 5746-5752
20. J.J. Killion I.J. Fidler Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators Pharmacol. Ther. 78 1998 141-154
21. E.S. Kleinerman J.B. Gano D.A. Johnston R.S. Benjamin N. Jaffe Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma Am. J. Clin. Oncol. 18 1995 93-99
22. A.H. Klimp E.G. de Vries G.L. Scherphof T. Daemen A potential role of macrophage activation in the treatment of cancer Crit. Rev. Oncol. Hematol. 44 2002 143-161
23. T. Knittel M. Mehde D. Kobold B. Saile C. Dinter G. Ramadori Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: Regulation by TNF-alpha and TGF-beta1 J. Hepatol. 30 1999 48-60
24. P.A. Knolle G. Gerken Local control of the immune response in the liver Immunol. Rev. 174 2000 21-34
25. D.L. Laskin Nonparenchymal cells and hepatotoxicity Semin. Liver Dis. 10 1990 293-304
26. D.L. Laskin B. Weinberger J.D. Laskin Functional heterogeneity in liver and lung macrophages J. Leukoc. Biol. 70 2001 163-170
27. M. Liljefors B. Nilsson J. Fagerberg P. Ragnhammar H. Mellstedt J.E. Frodin Clinical effects of a chimeric anti-EpCAM monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma Int. J. Oncol. 26 2005 1581-1589
28. L.X. Liu W.H. Zhang H.C. Jiang Current treatment for liver metastases from colorectal cancer World J. Gastroenterol. 9 2003 193-200
29. R. Malafosse C. Penna C.A. Sa B. Nordlinger Surgical management of hepatic metastases from colorectal malignancies Ann. Oncol. 12 2001 887-894
30. A. Mantovani S. Sozzani M. Locati P. Allavena A. Sica Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol. 23 2002 549-555
31. A.K. Mels M.G. Statius Muller P.A. van Leeuwen B.M. von Blomberg R.J. Scheper M.A. Cuesta R.H. Beelen S. Meijer Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma Br. J. Surg. 88 2001 539-544
32. D. Metcalf The granulocyte-macrophage colony-stimulating factors Science 229 1985 16-22
33. O.R. Mook J. Van Marle H. Vreeling-Sindelarova R. Jonges W.M. Frederiks C.J. Van Noorden Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver Hepatology 38 2003 295-304
34. M. Naito G. Hasegawa Y. Ebe T. Yamamoto Differentiation and function of Kupffer cells Med. Electron Microsc. 37 2004 16-28
35. T. Nakamura Structure and function of hepatocyte growth factor Prog. Growth Factor Res. 3 1991 67-85
36. J. Neidhart K.O. Allen D.L. Barlow M. Carpenter D.R. Shaw P.L. Triozzi R.M. Conry Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor Vaccine 22 2004 773-780
37. R. Nelson S. Freels Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver Cochrane Database Syst. Rev. 2004 CD003770
38. J.W. Pollard Tumour-educated macrophages promote tumour progression and metastasis Nat. Rev. Cancer 4 2004 71-78
39. B.A. Pulaski M.J. Smyth S. Ostrand-Rosenberg Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma Cancer Res. 62 2002 4406-4412
40. A.G. Renehan M. Egger M.P. Saunders S.T. O'Dwyer Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials Br. Med. J. 324 2002 813
41. G. Riethmuller E. Holz G. Schlimok W. Schmiegel R. Raab K. Hoffken R. Gruber I. Funke H. Pichlmaier H. Hirche P. Buggisch J. Witte R. Pichlmayr Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial J. Clin. Oncol. 16 1998 1788-1794
42. C. Rushfeldt B. Sveinbjornsson R. Seljelid B. Smedsrod Early events of hepatic metastasis formation in mice: Role of Kupffer and NK-cells in natural and interferon-gamma-stimulated defense J. Surg. Res. 82 1999 209-215
43. J.P. Sales P. Wind R. Douard P.H. Cugnenc S. Loric Blood dissemination of colonic epithelial cells during no-touch surgery for rectosigmoid cancer Lancet 354 1999 392
44. B. Schuurman G. Heuff R.H. Beelen S. Meyer Enhanced killing capacity of human Kupffer cells after activation with human granulocyte/ macrophage-colony-stimulating factor and interferon gamma Cancer Immunol. Immunother. 39 1994 179-184
45. B. Schuurman G. Heuff R.H. Beelen S. Meyer Enhanced human Kupffer cell-mediated cytotoxicity after activation of the effector cells and modulation of the target cells by interferon-gamma: A mechanistic study at the cellular level Cell Immunol. 165 1995 141-147
46. B. Schuurman H.J. Koenen R.H. Beelen S. Meyer Granulocyte macrophage colony stimulating factor pretreatment induces an increase of rat Kupffer cells with enhanced cytotoxicity in vitro and prevention of tumor outgrowth in vivo Anticancer Drugs 8 1997 269-275
47. S. Seki Y. Habu T. Kawamura K. Takeda H. Dobashi T. Ohkawa H. Hiraide The liver as a crucial organ in the first line of host defense: The roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses Immunol. Rev. 174 2000 35-46
48. C. Sietses R.H. Beelen S. Meijer M.A. Cuesta Immunological consequences of laparoscopic surgery, speculations on the cause and clinical implications Langenbecks Arch. Surg. 384 1999 250-258
49. P.D. Smith C.L. Lamerson H.L. Wong L.M. Wahl S.M. Wahl Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function J. Immunol. 144 1990 3829-3834
50. J. Uchida Y. Hamaguchi J.A. Oliver J.V. Ravetch J.C. Poe K.M. Haas T.F. Tedder The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy J. Exp. Med. 199 2004 1659-1669
51. H.H. van Ojik L. Bevaart C.E. Dahle A. Bakker M.J. Jansen M.J. van Vugt J.G. van de Winkel G.J. Weiner CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations Cancer Res. 63 2003 5595-5600
52. N. van Rooijen A. Sanders Elimination, blocking, and activation of macrophages: Three of a kind? J. Leukoc. Biol. 62 1997 702-709
53. M.L. Veronese P.J. O'Dwyer Monoclonal antibodies in the treatment of colorectal cancer Eur. J. Cancer 40 2004 1292-1301
54. M.A. Williams S.M. Kelsey A.C. Newland GM-CSF and stimulation of monocyte/macrophage function in vivo relevance and in vitro observations Eur. J. Cancer 35 Suppl. 3 1999 S18-S22